CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands	Total	At the Market Offering	Initial Public Offering	Underwritten Offering	Underwriters	Redeemable Convertible Preferred Stock	Common Stock	Common Stock At the Market Offering	Common Stock Initial Public Offering	Common Stock Underwritten Offering	Common Stock Underwriters	Additional Paid-in Capital	Additional Paid-in Capital At the Market Offering	Additional Paid-in Capital Initial Public Offering	Additional Paid-in Capital Underwritten Offering	Additional Paid-in Capital Underwriters	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ (47,411)																$ (27)	$ (47,384)
Redeemable convertible preferred stock, Beginning balance at Dec. 31, 2021						$ 109,319
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2021						11,409,488
Beginning balance, shares at Dec. 31, 2021							2,730,298
Redeemable convertible preferred stock, Accretion to redemption value and cumulative dividends on preferred stock						$ 1,820
Accretion to redemption value and cumulative dividends on preferred stock	(1,820)											$ (437)						(1,383)
Redeemable convertible preferred stock, conversion of convertible preferred stock into common stock						$ (111,139)
Redeemable convertible preferred stock, conversion of convertible preferred stock into common stock, shares						(11,409,488)
Conversion of convertible preferred stock into common stock	111,139											111,139
Conversion of convertible preferred stock into common stock, shares							11,409,488
Issuance of common stock, net of commissions and offering costs			$ 60,836											$ 60,836
Issuance of common stock, net of commissions and offering costs, shares									4,600,000
Vesting of early exercised stock options	14											14
Repurchase of early exercised stock options	(11)											(11)
Repurchase of early exercised stock options, shares							(27,128)
Stock-based compensation	449											449
Unrealized gain (loss) on available-for-sale investments	(131)																(131)
Net loss	(7,655)																	(7,655)
Ending balances at Mar. 31, 2022	115,410											171,990					(158)	(56,422)
Ending balances, shares at Mar. 31, 2022							18,712,658
Beginning balance at Dec. 31, 2021	(47,411)																(27)	(47,384)
Redeemable convertible preferred stock, Beginning balance at Dec. 31, 2021						$ 109,319
Redeemable convertible preferred stock, beginning balance, shares at Dec. 31, 2021						11,409,488
Beginning balance, shares at Dec. 31, 2021							2,730,298
Net loss	(29,114)		(29,100)
Ending balances at Sep. 30, 2022	105,573											183,995					(541)	(77,881)
Ending balances, shares at Sep. 30, 2022							19,402,658
Beginning balance at Mar. 31, 2022	115,410											171,990					(158)	(56,422)
Beginning balance, shares at Mar. 31, 2022							18,712,658
Issuance of common stock, net of commissions and offering costs					$ 9,530											$ 9,530
Issuance of common stock, net of commissions and offering costs, shares											690,000
Vesting of early exercised stock options	3											3
Stock-based compensation	1,242											1,242
Unrealized gain (loss) on available-for-sale investments	(202)																(202)
Net loss	(10,120)																	(10,120)
Ending balances at Jun. 30, 2022	115,863											182,765					(360)	(66,542)
Ending balances, shares at Jun. 30, 2022							19,402,658
Vesting of early exercised stock options	2											2
Stock-based compensation	1,228											1,228
Unrealized gain (loss) on available-for-sale investments	(181)																(181)
Net loss	(11,339)																	(11,339)
Ending balances at Sep. 30, 2022	105,573											183,995					(541)	(77,881)
Ending balances, shares at Sep. 30, 2022							19,402,658
Beginning balance at Dec. 31, 2022	95,372											185,469					(374)	(89,723)
Beginning balance, shares at Dec. 31, 2022							19,402,658
Issuance of common stock under the ESPP	199											199
Issuance of common stock under the ESPP, Shares							23,794
Vesting of early exercised stock options	2											2
Stock-based compensation	2,068											2,068
Unrealized gain (loss) on available-for-sale investments	199																199
Net loss	(15,323)																	(15,323)
Ending balances at Mar. 31, 2023	82,517											187,738					(175)	(105,046)
Ending balances, shares at Mar. 31, 2023							19,426,452
Beginning balance at Dec. 31, 2022	$ 95,372											185,469					(374)	(89,723)
Beginning balance, shares at Dec. 31, 2022							19,402,658
Issuance of common stock upon the exercised of stock options, shares	15,000
Net loss	$ (47,834)		$ (47,800)
Ending balances at Sep. 30, 2023	$ 138,969											276,648					(122)	(137,557)
Redeemable convertible preferred stock, ending balance, shares at Sep. 30, 2023	0
Ending balances, shares at Sep. 30, 2023							29,741,445
Beginning balance at Mar. 31, 2023	$ 82,517											187,738					(175)	(105,046)
Beginning balance, shares at Mar. 31, 2023							19,426,452
Issuance of common stock, net of commissions and offering costs		$ 19,050											$ 19,050
Issuance of common stock, net of commissions and offering costs, shares								2,502,000
Vesting of early exercised stock options	2											2
Stock-based compensation	1,943											1,943
Unrealized gain (loss) on available-for-sale investments	56																56
Net loss	(15,804)																	(15,804)
Ending balances at Jun. 30, 2023	87,764											208,733					(119)	(120,850)
Ending balances, shares at Jun. 30, 2023							21,928,452
Issuance of common stock under the ESPP	167											167
Issuance of common stock under the ESPP, Shares							20,215
Issuance of common stock upon exercise of stock options	99											99
Issuance of common stock upon the exercised of stock options, shares							15,000
Issuance of common stock, net of commissions and offering costs				$ 65,479											$ 65,479
Issuance of common stock, net of commissions and offering costs, shares										7,777,778
Vesting of early exercised stock options	1											1
Stock-based compensation	2,169											2,169
Unrealized gain (loss) on available-for-sale investments	(3)																(3)
Net loss	(16,707)																	(16,707)
Ending balances at Sep. 30, 2023	$ 138,969											$ 276,648					$ (122)	$ (137,557)
Redeemable convertible preferred stock, ending balance, shares at Sep. 30, 2023	0
Ending balances, shares at Sep. 30, 2023							29,741,445